Oracle Commodity Holding Corp., a mining royalty company specializing in precious metals and critical minerals, has announced an increase in its non-brokered private placement financing due to high demand. The offering, initially set at 7 million units priced at $0.035 per unit, has been upsized to 7.5 million units, raising potential gross proceeds from $245,000 to $262,500. Each unit includes one common share and one transferable common share purchase warrant, allowing the holder to acquire an additional share at an exercise price of $0.06 for three years from issuance.
Company insiders are expected to subscribe for up to 1.75 million units, contributing up to $61,250 in gross proceeds. This transaction is considered a related party transaction under Multilateral Instrument 61-101. However, the company is exempt from formal valuation and minority shareholder approval requirements, as insiders' participation will not exceed 25% of the company's market capitalization. The offering is subject to regulatory approvals, including from the TSX Venture Exchange, and the units will be issued privately under exemptions from prospectus requirements. The proceeds from this offering will be used for general corporate purposes and to pay for the acquisition of a 2% royalty from U.S. Fluorspar LLC over certain fluorspar projects. This strategic financial move is led by CEO Anthony Garson, who is steering the company through this growth phase.
The company's focus on expanding its royalty interests aligns with its long-term strategy to enhance shareholder value. In contrast, Oracle Corporation (NYSE:ORCL) is a major player in the technology sector, with a price-to-earnings (P/E) ratio of approximately 64.39. The company's price-to-sales ratio is about 13.47, and its enterprise value to sales ratio is around 15.08.
Oracle's enterprise value to operating cash flow ratio is approximately 41.34, with an earnings yield of about 1.55%. The company has a debt-to-equity ratio of roughly 4.36, indicating a significant level of debt compared to its equity. Additionally, Oracle's current ratio is approximately 0.62, suggesting that its current assets are not sufficient to cover its current liabilities.
On September 26, 2025, UBS set a price target of $364 for Oracle, as highlighted by UBS. At the time of this announcement, Oracle's stock price was $291.41, indicating a potential increase of approximately 24.91% from the current price. This reflects the market's positive outlook on Oracle's future performance, despite its high debt levels and low current ratio.
